Author

Andrea Pavesi

Agency for Science, Technology and ResearchORCID 0000-0003-2777-1043Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Assay:CITE-seq· 1

Frequent Co-Authors

Andrea GarmillaiD· 1 shared Anisha Datta· 1 shared Benjamin BeckiD· 1 shared Caleb R. PereziD· 1 shared Diego Japón-Ruiz· 1 shared Douglas A. LauffenburgeriD· 1 shared Eloine Garcia· 1 shared Fabiana MoresiiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Andrea GarmillaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCell Death and DiseasePeer-reviewedMay 29, 2026

CDK4/6 Inhibition Uncovers Subtype-Specific Vulnerabilities and Immune-Related Responses in Esophageal Squamous Cell Carcinoma.

Fabiana Moresi, Diego Japón-Ruiz, Matteo Serra…·Xavier Bisteau

This study evaluates palbociclib as a first-line therapy in eSCC, identifying response subtypes and showing immune activation through replication stress and DNA damage.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologyJournal for ImmunoTherapy of CancerPeer-reviewedFeb 1, 2025

Pooled screening for CAR function identifies novel IL13Rα2-targeted CARs for treatment of glioblastoma

Khloe S. Gordon, Caleb R. Perez, Andrea Garmilla…·Michael E. Birnbaum

The paper identifies novel IL13Rα2-targeted CARs with improved anti-glioblastoma efficacy using a pooled screening platform.

10 citations

humanCITE-seq

𝕏 PostBluesky